OPERATING AND REPORTABLE SEGMENTS (Tables)

6 Months Ended

Jun. 30, 2014

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Segment Reporting Information

(in thousands)

	Three Months Ended   June 30,						Six Months Ended   June 30,
	2014			2013			2014			2013
Results of Operations:
Revenue:
Infusion Services - product revenue	$	225,277		$	150,559		$	441,180		$	300,583
Infusion Services - service revenue	5,271			5,424			10,437			9,668
Total Infusion Services revenue	230,548			155,983			451,617			310,251
PBM Services - service revenue	16,577			16,340			34,801			43,092
Total revenue	$	247,125		$	172,323		$	486,418		$	353,343
Adjusted EBITDA by Segment before corporate overhead:
Infusion Services	$	16,194		$	13,995		$	31,155		$	25,992
PBM Services	1,837			4,916			3,512			11,111
Total Segment Adjusted EBITDA	18,031			18,911			34,667			37,103
Corporate overhead	(7,016		)	(8,132		)	(14,492		)	(16,048		)
Interest expense, net	(9,135		)	(6,508		)	(19,634		)	(12,986		)
Income tax (expense) benefit	(3,063		)	(146		)	(6,554		)	29
Depreciation	(3,958		)	(2,527		)	(7,794		)	(4,945		)
Amortization of intangibles	(1,620		)	(1,710		)	(3,323		)	(3,792		)
Stock-based compensation expense	(1,998		)	(3,860		)	(4,884		)	(5,833		)
Acquisition and integration expenses	(5,333		)	(3,512		)	(11,832		)	(8,135		)
Restructuring and other expenses and investments	(4,519		)	(1,812		)	(10,021		)	(3,052		)
Loss from continuing operations, net of income taxes	$	(18,611	)	$	(9,296	)	$	(43,867	)	$	(17,659	)
Supplemental Operating Data
							June 30, 2014			December 31, 2013
Total Assets:
Infusion Services							$	806,127		$	793,475
PBM Services							27,203			25,239
Corporate unallocated, including cash and cash equivalents							50,485			53,169
Assets from discontinued operations							—			64,959
Assets associated with discontinued operations, not sold							7			16
Total Assets							$	883,822		$	936,858